[Therapeutic effect of intravenous calcium antagonist tetrandrine in the treatment of paroxysmal supraventricular tachycardia].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000470:Alkaloids / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D044182:Benzylisoquinolines; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D013617:Tachycardia, Supraventricular / Q000188:drug therapy*
D000470:Alkaloids; D000889:Anti-Arrhythmia Agents; D044182:Benzylisoquinolines; D002121:Calcium Channel Blockers; C009438:tetrandrine